These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 13427602)

  • 61. [The treatment of chronic constipation of immobilized patients with polymers of polyoxyethylene and polyoxy-1,2-propanediol].
    VINCENT ; GIROUX
    Lyon Med; 1959 Dec; 91():1079-85. PubMed ID: 13855255
    [No Abstract]   [Full Text] [Related]  

  • 62. The hypnotic effect of a new propanediol dicarbamate, W 583 (a double blind, double dose study).
    BODI T; LEVY HA; NODINE JH; MOYER JH
    Am J Med Sci; 1960 Feb; 239():207-12. PubMed ID: 13801928
    [No Abstract]   [Full Text] [Related]  

  • 63. Fatal propylene glycol toxicosis in a horse.
    Dorman DC; Haschek WM
    J Am Vet Med Assoc; 1991 May; 198(9):1643-4. PubMed ID: 2061183
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [2-Methyl-2-n-propyl-1, 3-propandiol-dicarbamate (meprobamate); experimental results, clinical experiences and own studies on the determination of excretion products].
    RIEBELING C
    Arzneimittelforschung; 1957 Mar; 7(3):181-5. PubMed ID: 13425940
    [No Abstract]   [Full Text] [Related]  

  • 65. Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate.
    Rho JM; Donevan SD; Rogawski MA
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1383-91. PubMed ID: 9067327
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Point of action of 3-o-toloxy-1, 2-propanediol and effects of nervous system.
    FINKELMAN I
    Arch Neurol Psychiatry; 1949 Jun; 61(6):680-7. PubMed ID: 18145436
    [No Abstract]   [Full Text] [Related]  

  • 67. INTERACTION OF PLASMA PROTEIN WITH RELATED 1,3-PROPANEDIOL DICARBAMATES.
    DOUGLAS JF; BRADSHAW WH; LUDWIG BJ; POWERS D
    Biochem Pharmacol; 1964 Mar; 13():537-9. PubMed ID: 14157619
    [No Abstract]   [Full Text] [Related]  

  • 68. Some attempts to prolong the duration of action of 2,2-diethyl-1,3-propanediol (prenderol).
    SLATER IH; O'LEARY JF; PRIBYL EJ
    J Am Pharm Assoc Am Pharm Assoc; 1954 Sep; 43(9):547-50. PubMed ID: 13201478
    [No Abstract]   [Full Text] [Related]  

  • 69. [N-Alkyl derivatives of phenyl-1-amino-2-propanediol-1.3; application to synthesis of an N-methylate of chloromycetin].
    FUNKE A; KORNMANN P
    C R Hebd Seances Acad Sci; 1952 Oct; 235(14):726-8. PubMed ID: 13033140
    [No Abstract]   [Full Text] [Related]  

  • 70. In vitro metabolism of mephenesin, 3-o-tolyloyl-1,2-propanediol.
    MAASS AR; CAREY PL; HAMILTON RE; HEMING AE
    Proc Soc Exp Biol Med; 1960 Jan; 103():154-7. PubMed ID: 14419235
    [No Abstract]   [Full Text] [Related]  

  • 71. The preparation and pharmacological properties of the acid succinate of 3-(o-toloxy)-1,2-propanediol (myanesin).
    BERGER FM; RILEY RF
    J Pharmacol Exp Ther; 1949 Jul; 96(3):269-75. PubMed ID: 18133077
    [No Abstract]   [Full Text] [Related]  

  • 72. Hypersensitivity following ingestion of hydroxyzine (atarax) in a meprobamate-sensitive patient.
    COHEN AE; COHEN NK
    J Allergy; 1958; 29(6):542-4. PubMed ID: 13587125
    [No Abstract]   [Full Text] [Related]  

  • 73. [Early clinical experiments with 2-methyl-2-propyl-1,3-propandiol dicarbamate; new substance with sedative action].
    BALDUINI M
    Farmaco Prat; 1956 Oct; 11(10):565-70. PubMed ID: 13414830
    [No Abstract]   [Full Text] [Related]  

  • 74. The muscle relaxant properties of 2,2-dichloro-1-(p-chlorophenyl)-1,3-propanediol-O3-carbamate.
    BURKE JC; PAPANDRIANOS D; BRANNICK LJ; HASSERT GL
    Arch Int Pharmacodyn Ther; 1961 Nov; 134():216-23. PubMed ID: 13874881
    [No Abstract]   [Full Text] [Related]  

  • 75. Mutual antagonism and synergism between the central effects of nicotine and 2, 2-diethyl-1, 3-propanediol (prenderol).
    BLUM B
    Arch Int Pharmacodyn Ther; 1956 Sep; 107(3-4):449-52. PubMed ID: 13363516
    [No Abstract]   [Full Text] [Related]  

  • 76. [Contribution to the pharmacology of ethylal-gamma-trimethylammoniumpropanediol (2.268 F)].
    PANNIER R; VERBEKE R
    Arch Int Pharmacodyn Ther; 1947 Jun; 74(3-4):364-77. PubMed ID: 18900951
    [No Abstract]   [Full Text] [Related]  

  • 77. The pharmacological properties of 2-methyl-2-sec-butyl-1,3-propanediol dicarbamate (Mebutamate, W-583), a new centrally acting blood pressure lowering agent.
    BERGER FM; DOUGLAS JF; KLETZKIN M; LUDWIG BJ; MARGOLIN S
    J Pharmacol Exp Ther; 1961 Dec; 134():356-65. PubMed ID: 13867648
    [No Abstract]   [Full Text] [Related]  

  • 78. [Chemotherapeutic agents with structure similan to chloramphenicol (chloromycetin). I].
    CESTARI A; BEZZI S
    Farmaco Sci Tec; 1950; 5(6):649-54. PubMed ID: 14813290
    [No Abstract]   [Full Text] [Related]  

  • 79. Effect of 3-orthotoloxy-1,2-propanediol (tolserol, myanesin) upon electrogram of human cortex and subcortex.
    SPIEGEL EA; WYCIS HT
    Proc Soc Exp Biol Med; 1949 Nov; 72(2):446-8. PubMed ID: 15408350
    [No Abstract]   [Full Text] [Related]  

  • 80. [Propylene glycol: its properties and uses in pharmaceutical technics].
    GIALDI F; BARUFFINI A
    Farmaco Prat; 1955 Jun; 10(6):278-86. PubMed ID: 13241534
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.